JMGMX | PMBCX | JMGMX / PMBCX | |
Total Expense Ratio | 0.65 | 1.75 | 37% |
Annual Report Gross Expense Ratio | 0.69 | 1.75 | 39% |
Fund Existence | 14 years | 19 years | - |
Gain YTD | 9.184 | 6.239 | 147% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 15000000 | 1000 | 1,500,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 12.7B | 32.9B | 39% |
Annual Yield % from dividends | 0.00 | 0.00 | - |
Returns for 1 year | 10.08 | 6.03 | 167% |
Returns for 3 years | 35.52 | 34.96 | 102% |
Returns for 5 years | 15.54 | 33.61 | 46% |
Returns for 10 years | 87.24 | 80.14 | 109% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
GNOM | 9.22 | 0.05 | +0.55% |
Global X Genomics & Biotechnology ETF | |||
IWR | 95.70 | 0.21 | +0.22% |
iShares Russell Mid-Cap ETF | |||
TTEQ | 30.63 | 0.04 | +0.14% |
T. Rowe Price Technology ETF | |||
AVSD | 70.01 | 0.01 | +0.02% |
Avantis Responsible International Eq ETF | |||
TOUS | 33.23 | -0.08 | -0.24% |
T. Rowe Price International Equity ETF |